至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The Effect of Ligand Mobility on the Cellular Interaction of Multivalent Nanoparticles

Macromol Biosci. 2020; 
Maslanka Figueroa S, Fleischmann D, Beck S, Goepferich A.
Products/Services Used Details Operation
Peptide Synthesis … Inc (Allen, TX) Lysine N-modified Angiotensin-I (Lys-Ang-I) and Ang-II (Lys-Ang-II) (purity > 98%) were purchased from Genscript (Piscataway, NJ) EXP3174 was purchased from Santa Cruz Biotechnology (Dallas, TX) Fura … Get A Quote

摘要

Multivalent nanoparticle binding to cells can be of picomolar avidity making such interactions almost as intense as those seen with antibodies. However, reducing nanoparticle design exclusively to avidity optimization by the choice of ligand and its surface density does not sufficiently account for controlling and understanding cell-particle interactions. Cell uptake, for example, is of paramount significance for a plethora of biomedical applications and does not exclusively depend on the intensity of multivalency. In this study, it is shown that the mobility of ligands tethered to particle surfaces has a substantial impact on particle fate upon binding. Nanoparticles carrying angiotensin-II tethered to highly ... More

关键词